By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SiteOne Therapeutics 

203 Enterprise Boulevard
Suite 3
Bozeman   Montana  59718  U.S.A.
Phone: 4064614618 Fax: n/a


SEARCH JOBS

SiteOne Therapeutics, headquartered in Bozeman, Montana with a research team in San Francisco, California, is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. The company’s therapeutic candidates are highly selective sodium ion channel 1.7 (NaV1.7) inhibitors based on naturally occurring small molecules. Given the critical role that NaV1.7 plays in the generation and conduction of pain signals, combined with the urgent need for new, non-opioid pain therapies, SiteOne is focused on advancing its lead products to serve patients that suffer from moderate to severe pain.

YEAR FOUNDED:

2010

LEADERSHIP:

Founders: Sandip Biswal, Justin Du Bois, David Yeomans, John Mulcahy, and George Milijanich

Founder and CSO: George Miljanich

CEO: Stan E. Abel


Key Statistics


Email: info@site1therapeutics.com
Ownership: Private

Web Site: SiteOne Therapeutics
Employees:
Symbol: 
 









Company News
//-->